An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis
An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis
复制标题
DOI:
10.1016/j.neulet.2009.02.048
复制
发表时间:
2009-05-15
影响因子:
2.5
通讯作者:
Mori, Norio
中科院分区:
文献类型:
--
作者:
Nakamura, Kazuhiko;Sekine, Yoshimoto;Mori, Norio
Methamphetamine continues to be the most widely abused drug in Japan. Chronic methamphetamine users show psychiatric signs, including methamphetamine psychosis. Monoamine oxidase A (MAOA) is one of the major enzymes responsible for the degradation of neurotransmitters. Abnormalities in MAO levels have been related to a wide range of psychiatric disorders. We examined whether or not the MAOA-u variable-number tandem repeat (VNTR) has a functional polymorphism in methamphetamine psychosis and whether or not such a polymorphism is related to the prolongation of psychosis. As expected, there was a significant difference in the MAOA-u VNTR between males with persistent versus transient methamphetamine psychosis (p = 0.018, odds ratio (OR) = 2.76, 95% CI: 1.18-6.46). Our results suggest that the high-activity allele class of MAOA-u VNTR in males may be involved in susceptibility to a persistent course of methamphetamine psychosis. We found no differences among females. The sample size of females with methamphetamine psychosis was too small to have significant analysis. (C) 2009 Elsevier Ireland Ltd. All rights reserved.